Skip to content

The research of Chinese medicine Early intervention for normal high blood pressure values vascular protecting function.

The high quality research of antihypertensive therapy in TCM model community.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IDR-15007540
Enrollment
Unknown
Registered
2015-10-29
Start date
1990-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-normal blood pressure

Interventions

Intervention and control groups:Traditional Chinese medicine from Fried fine particles vs control

Sponsors

Affiliated Hospital of Shandong University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Aged 30 to 55, males or females; 2. Clearly not have essential hypertension history in the past, nearly four weeks did not take antihypertensive drugs. Right arm Brachial artery sesbp 130~139mmhg,sedbp 85~89mmhg which be not measured continuity three times in the same day; 3. Carotid pulse conduction velocity >10m/s; 4. Have at least one cardiovascular risk factors: Abdominal obesity (Waist circumference male >=85cm female>=80cm)or overweight (bmi>=27kg/m2), Impaired fasting glucose or diabetes, smoking, lack of physical activity, dyslipidemia, family history of early onset of cardiovascular disease or stroke (Immediate family members of men onset age<55, women onset age<65); 5. In accordance with ganhuokangsheng Standard syndromes; 6. voluntary to these research, writte informed consent.

Exclusion criteria

Exclusion criteria: 1. With 12 months history cerebrovascular disease and 3 months history of acute coronary syndromes decompensated heart failure, Severe liver and kidney dysfunction, Kidney disease activity; 2. Allergies or allergic to medicines.

Design outcomes

Primary

MeasureTime frame
cfPWV;

Secondary

MeasureTime frame
FMD;AIP75;cSBP;

Countries

China

Contacts

Public ContactYang Chuanhua
wangjianlufeng@126.com+86 13853112726

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026